Skip to main content
. 2023 Nov 7;44(2):239–251. doi: 10.1177/0271678X231212378

Figure 6.

Figure 6.

FosDT levels are regulated by NF-κB. When treated with NF-κB inhibitor BAY 11-7082 (IP) at 30 min of reperfusion following transient MCAO, FosDT+/+ rats showed significantly reduced levels of FosDT (a) and Fos mRNA (b) at 12 h of reperfusion compared with vehicle control. FosDT−/− rats showed no FosDT expression (a) and no change in Fos levels (b) by BAY 11-7082 treatment. Values are mean ± SD (n = 4/group). *p < 0.05 compared with FosDT+/+ sham group and #p < 0.05 compared with FosDT+/+ MCAO group treated with the vehicle by one-way ANOVA followed by Sidak’s multiple comparisons post-test.